Differential effects of prostaglandins E 1 , E 2 , F 1   and F 2   on adrenergic vasoconstriction in the dog hindpaw.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D004285:Dogs; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006614:Hindlimb / Q000098:blood supply / Q000187:drug effects / Q000294:innervation; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011453:Prostaglandins / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine